ArticleSurgical endoscopy2025
Uncut Roux-en-Y for very small remnant stomach in gastric cancer: surgical advantages and nutritional outcomes.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe optimal reconstruction method after laparoscopic distal gastrectomy (LDG) for gastric cancer remains controversial. This study evaluates the novel approach of subtotal gastrectomy with preservation of a small remnant stomach (SRS) combined with uncut Roux-en-Y (URY) reconstruction, focusing on surgical feasibility, complications, and nutritional outcomes.
methodsA retrospective analysis of patients undergoing LDG (2017-2023) was conducted. To minimize selection bias between the URY (n = 175) and conventional Roux-en-Y (RY) (n = 69) groups, we performed 1:1 propensity score matching (PSM). Subgroup analysis was also conducted on URY patients, comparing those with SRS (n = 33) to those with a conventional remnant stomach (CRS) (n = 142), with PSM applied to this comparison as well.
resultsAfter PSM, the baseline characteristics of the URY and RY groups (n = 49 each) were well-balanced. In the matched cohort, the URY group demonstrated significantly shorter operation time, less intraoperative blood loss, and shorter postoperative hospital stays compared to the RY group. Similarly, after matching, perioperative and nutritional outcomes were comparable between the SRS and CRS subgroups (n = 23 each).
conclusionAfter adjusting for baseline confounders using PSM, URY reconstruction is associated with significant surgical advantages over conventional RY. Furthermore, preserving an SRS with URY reconstruction is a safe, feasible, and surgically efficient approach, yielding short-to-intermediate term outcomes comparable to those with a conventional remnant.
Indexed as
Identifiers
40855000What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.